News | July 22, 2023
Lupin launches Luforbec 100/6 for adult asthma and COPD treatment in Germany
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
First of its kind screening for Glaucoma at grass root level over 10k screened already
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Cipla has a robust governance model focused on sustainability
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Subscribe To Our Newsletter & Stay Updated
